Eam Investors, LLC Chembio Diagnostics, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$3.18 - $15.54 $380,537 - $1.86 Million	-119,666 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.36 - $5.6 $282,411 - $670,129	119,666 New	119,666 $613,000
Q4 2018 Feb 13, 2019	SELL	$4.95 - $10.5 $363,993 - $772,107	-73,534 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$9.2 - $11.5 $1,904 - $2,380	207 Added 0.28%	73,534 $772,000
Q2 2018 Aug 03, 2018	BUY	$7.8 - $11.1 $571,950 - $813,929	73,327 New	73,327 $814,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.